Search

Search Constraints

You searched for: Author/Creator Ruppert-Roth A author non-byline.

Search Results

1. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Issue 6 (30th January 2014)